A mechanism that won the 2006 Nobel and became a six-figure human drug class is now the first RNA pesticide you can spray on a field, and the US patent race was quietly won years ago by the old GMO giants.
Six approved siRNA drugs and zero of them treat infection or cancer. The COVID lab tested every prediction in Kurzweil’s biosecurity chapter, and the molecule he championed won the wrong race.
Seven approved RNAi drugs, one CRISPR medicine for sickle cell, and a stem-cell cure inching toward filing — but every one arrived through mechanisms Kurzweil did not forecast in 2005.